BRPI0614412A2 - composto, e, composição farmacêutica - Google Patents
composto, e, composição farmacêuticaInfo
- Publication number
- BRPI0614412A2 BRPI0614412A2 BRPI0614412A BRPI0614412A BRPI0614412A2 BR PI0614412 A2 BRPI0614412 A2 BR PI0614412A2 BR PI0614412 A BRPI0614412 A BR PI0614412A BR PI0614412 A BRPI0614412 A BR PI0614412A BR PI0614412 A2 BRPI0614412 A2 BR PI0614412A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70400905P | 2005-07-29 | 2005-07-29 | |
| PCT/US2006/029125 WO2007016212A1 (en) | 2005-07-29 | 2006-07-27 | Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0614412A2 true BRPI0614412A2 (pt) | 2016-11-22 |
Family
ID=37309001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0614412A BRPI0614412A2 (pt) | 2005-07-29 | 2006-07-27 | composto, e, composição farmacêutica |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7291643B2 (pt) |
| EP (1) | EP1910285A1 (pt) |
| JP (1) | JP5185114B2 (pt) |
| KR (1) | KR20080031915A (pt) |
| CN (1) | CN101233104A (pt) |
| AR (1) | AR056005A1 (pt) |
| AU (1) | AU2006275833B2 (pt) |
| BR (1) | BRPI0614412A2 (pt) |
| CA (1) | CA2612977A1 (pt) |
| CR (1) | CR9627A (pt) |
| EC (1) | ECSP088147A (pt) |
| GT (1) | GT200600336A (pt) |
| HN (1) | HN2008000135A (pt) |
| IL (1) | IL188314A (pt) |
| MX (1) | MX2008001338A (pt) |
| NO (1) | NO20076683L (pt) |
| PE (1) | PE20070404A1 (pt) |
| RU (1) | RU2007148077A (pt) |
| SA (1) | SA06270246B1 (pt) |
| TW (1) | TW200734302A (pt) |
| UA (1) | UA92500C2 (pt) |
| WO (1) | WO2007016212A1 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20070182A1 (es) * | 2005-07-29 | 2007-03-06 | Wyeth Corp | Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona |
| PE20070341A1 (es) * | 2005-07-29 | 2007-04-13 | Wyeth Corp | Derivados de pirrol como moduladores del receptor de progesterona |
| TW200848019A (en) * | 2007-03-06 | 2008-12-16 | Wyeth Corp | Aryl sulfonamides useful for modulation of the progesterone receptor |
| TW200848021A (en) * | 2007-03-06 | 2008-12-16 | Wyeth Corp | Sulfonylated heterocycles useful for modulation of the progesterone receptor |
| BRPI0819571A2 (pt) * | 2007-12-20 | 2019-09-24 | Teva Womenss Health Inc | "método para contracepção de emergência, pacote farmacêutico para contracepção de emergência e composição farmacêutica" |
| EP2914253B1 (en) | 2012-11-05 | 2018-01-03 | NantBioScience, Inc. | Cyclic sulfonamide containing derivatives as inhibitors of hedgehog signaling pathway |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4680413A (en) * | 1986-01-17 | 1987-07-14 | Nippon Soda Co., Ltd. | Process for the production of 3-phenyl-4-cyanopyrroles |
| US5310938A (en) * | 1987-07-29 | 1994-05-10 | American Cyanamid Company | Substituted arylpyrrole compounds |
| EP0339342A1 (de) * | 1988-04-23 | 1989-11-02 | Bayer Ag | N-Substituierte N-Amino-pyrrole |
| GB8903592D0 (en) * | 1989-02-16 | 1989-04-05 | Boots Co Plc | Therapeutic agents |
| DE4036645A1 (de) | 1990-11-16 | 1992-05-21 | Hoechst Ag | Substituierte azole, verfahren zu deren herstellung, deren enthaltende mittel und deren verwendung |
| JP2699024B2 (ja) | 1990-11-22 | 1998-01-19 | 富士写真フイルム株式会社 | 新規な色素形成カプラーおよび該カプラーを含有するハロゲン化銀カラー写真感光材料 |
| US5187168A (en) * | 1991-10-24 | 1993-02-16 | American Home Products Corporation | Substituted quinazolines as angiotensin II antagonists |
| US5236925A (en) * | 1991-10-24 | 1993-08-17 | American Home Products Corporation | Fused pyrimidines as angiotensin II antagonists |
| WO1994017059A1 (fr) | 1993-01-29 | 1994-08-04 | Nippon Soda Co., Ltd. | Derive heterocyclique |
| EP0842923B1 (en) * | 1995-06-07 | 2006-03-01 | Nippon Shinyaku Company, Limited | Pyrrole derivatives and medicinal composition |
| US6013421A (en) * | 1996-07-19 | 2000-01-11 | Fuji Photo Film Co., Ltd. | Silver halide photographic light-sensitive material and image-forming method |
| US20010007867A1 (en) * | 1999-12-13 | 2001-07-12 | Yuhpyng L. Chen | Substituted 6,5-hetero-bicyclic derivatives |
| US6407101B1 (en) * | 1999-05-04 | 2002-06-18 | American Home Products Corporation | Cyanopyrroles |
| HUP0303415A2 (hu) * | 2001-03-09 | 2004-01-28 | Pfizer Products Inc. | Triazolopiridinek, mint gyulladásgátló anyagok és ezeket tartalmazó gyógyszerkészítmények |
| AP2002002460A0 (en) * | 2001-03-09 | 2002-06-30 | Pfizer Prod Inc | Novel benzimidazole anti-inflammatory compounds. |
| DE60205974T2 (de) * | 2001-04-04 | 2006-06-29 | Pfizer Products Inc., Groton | Neue Benzotriazole mit entzündungshemmender Wirkung |
| WO2004043926A1 (en) | 2002-11-11 | 2004-05-27 | Bayer Healthcare Ag | Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist |
| EP1594438B1 (fr) * | 2003-02-12 | 2013-07-17 | L'Oréal | Utilisation d'un inhibiteur de 15-hydroxy prostaglandine déshydrogénase pour favoriser la pigmentation de la peau ou des phanères |
| CA2562160C (en) | 2004-04-27 | 2013-05-28 | Wyeth | Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same |
| GT200500185A (es) * | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
| GT200500183A (es) | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos |
-
2006
- 2006-07-26 PE PE2006000915A patent/PE20070404A1/es not_active Application Discontinuation
- 2006-07-27 BR BRPI0614412A patent/BRPI0614412A2/pt not_active IP Right Cessation
- 2006-07-27 UA UAA200801075A patent/UA92500C2/ru unknown
- 2006-07-27 AU AU2006275833A patent/AU2006275833B2/en not_active Ceased
- 2006-07-27 RU RU2007148077/04A patent/RU2007148077A/ru not_active Application Discontinuation
- 2006-07-27 CN CNA2006800277588A patent/CN101233104A/zh active Pending
- 2006-07-27 CA CA002612977A patent/CA2612977A1/en not_active Abandoned
- 2006-07-27 TW TW095127519A patent/TW200734302A/zh unknown
- 2006-07-27 KR KR1020087002371A patent/KR20080031915A/ko not_active Ceased
- 2006-07-27 AR ARP060103257A patent/AR056005A1/es not_active Application Discontinuation
- 2006-07-27 GT GT200600336A patent/GT200600336A/es unknown
- 2006-07-27 US US11/494,226 patent/US7291643B2/en not_active Expired - Fee Related
- 2006-07-27 WO PCT/US2006/029125 patent/WO2007016212A1/en not_active Ceased
- 2006-07-27 MX MX2008001338A patent/MX2008001338A/es active IP Right Grant
- 2006-07-27 JP JP2008524136A patent/JP5185114B2/ja not_active Expired - Fee Related
- 2006-07-27 EP EP06774705A patent/EP1910285A1/en not_active Withdrawn
- 2006-07-29 SA SA06270246A patent/SA06270246B1/ar unknown
-
2007
- 2007-12-20 CR CR9627A patent/CR9627A/es not_active Application Discontinuation
- 2007-12-20 IL IL188314A patent/IL188314A/en not_active IP Right Cessation
- 2007-12-28 NO NO20076683A patent/NO20076683L/no not_active Application Discontinuation
-
2008
- 2008-01-28 HN HN2008000135A patent/HN2008000135A/es unknown
- 2008-01-28 EC EC2008008147A patent/ECSP088147A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2006275833A1 (en) | 2007-02-08 |
| IL188314A0 (en) | 2008-04-13 |
| US7291643B2 (en) | 2007-11-06 |
| MX2008001338A (es) | 2008-03-25 |
| KR20080031915A (ko) | 2008-04-11 |
| CN101233104A (zh) | 2008-07-30 |
| JP5185114B2 (ja) | 2013-04-17 |
| ECSP088147A (es) | 2008-02-20 |
| CA2612977A1 (en) | 2007-02-08 |
| TW200734302A (en) | 2007-09-16 |
| GT200600336A (es) | 2007-05-28 |
| AU2006275833B2 (en) | 2012-04-26 |
| IL188314A (en) | 2012-09-24 |
| CR9627A (es) | 2008-03-06 |
| JP2009502947A (ja) | 2009-01-29 |
| SA06270246B1 (ar) | 2010-11-22 |
| NO20076683L (no) | 2008-02-04 |
| HN2008000135A (es) | 2010-08-19 |
| EP1910285A1 (en) | 2008-04-16 |
| UA92500C2 (ru) | 2010-11-10 |
| RU2007148077A (ru) | 2009-09-10 |
| WO2007016212A1 (en) | 2007-02-08 |
| AR056005A1 (es) | 2007-09-12 |
| US20070027126A1 (en) | 2007-02-01 |
| PE20070404A1 (es) | 2007-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0614205A2 (pt) | composto, composição farmacêutica, e, uso de composto | |
| BRPI0618904A2 (pt) | composto, composição farmacêutica, e, uso do composto | |
| RU2398586C3 (ru) | Фармацевтическая композиция | |
| DK1940467T3 (da) | Lægemiddelsammensætning med langvarig frigivelse | |
| BRPI0511900A (pt) | composições farmacêuticas | |
| PL1954684T3 (pl) | Związek oksazolowy i kompozycja farmaceutyczna | |
| BRPI0613033A2 (pt) | composição oral | |
| NO20053161D0 (no) | Mikrobedrepende sammensetning. | |
| ITMI20050728A1 (it) | Formulazione innovativa | |
| NO20075628L (no) | Farmasøytiske formuleringer | |
| EP1788047A4 (en) | WATER REPELLENT / OIL-REPELLING COMPOSITION | |
| BRPI0608885A2 (pt) | composto de isômero c de sdz-rad, composição farmacêutica, e, embalagem farmacêutica | |
| NO20055686D0 (no) | Sammensetning | |
| ATE535505T1 (de) | Landwirtschaftliche zusammensetzung | |
| BRPI0807078A2 (pt) | Composto, e, formulação farmacêutica | |
| DK1725218T3 (da) | Farmaceutisk sammensætning omfattende pimobendan | |
| DK1957073T3 (da) | Lægemiddel | |
| DK2033629T3 (da) | Fast farmaceutisk sammensætning omfattende valsartan | |
| DK1741339T3 (da) | Pesticid sammensætning | |
| DE602006020863D1 (de) | Antimikrobielle zusammensetzung | |
| DE602005017191D1 (de) | Geruchsreduzierte waschstück-zusammensetzung | |
| EP1937255A4 (en) | PHARMACEUTICAL COMPOSITION | |
| BRPI0611748A2 (pt) | composto, composição farmacêutica, e, uso de uma composição farmacêutica | |
| DE502006001779D1 (de) | Allylorganopolysiloxane aufweisende vernetzbare zusammensetzungen | |
| BRPI0614413A2 (pt) | composto, e, composição farmacêutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06G | Technical and formal requirements: other requirements [chapter 6.7 patent gazette] |
Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE BASEADO NO ARTIGO 216 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO NO ORIGINAL, TRASLADO OU FOTOCOPIA AUTENTICADA. |
|
| B11Z | Dismissal: petition dismissal - article 216, par 2 of industrial property law |
Free format text: REFERENTE A PETICAO NO 20080015065/RJ DE 29/01/2008. |
|
| B06H | Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette] |
Free format text: O DESPACHO 6.7 DA RPI NO 2140 DE 10/01/2012 ESTA SENDO ANULADO TENDO POR BASE A DETERMINACAO DO DIRETOR DE PATENTES, A QUAL E CALCADA NO PARECER NO 0003-2014 - AGU/PGF/PFE/INPI/COOPHI-LBC-1.0. |
|
| B11M | Decision cancelled [chapter 11.13 patent gazette] |
Free format text: O DESPACHO 11.6.1 DA RPI NO 2186 DE 27/11/2012 ESTA SENDO ANULADO TENDO POR BASE A DETERMINACAO DO DIRETOR DE PATENTES, A QUAL E CALCADA NO PARECER NO 0003-2014 - AGU/PGF/PFE/INPI/COOPHI-LBC-1.0. |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |